Filed: 2/17/2026ACC: 0001193125-26-053978
📋 What this filing means
MWG CAPH LTD filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $72.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$72.37M
Total AUM (reported)
4.07M
Total Shares
Allocation by class
COM$41.34M57.1%
COM NEW$31.03M42.9%
Portfolio Concentration
Top 3$72.37M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.07M
Sole
Full voting authority
4.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BEAM THERAPEUTICS INC
DFNDShares1.27M
TypeSH
Market value$35.12M
48.53%
Sole
1.27M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
DFNDShares1.01M
TypeSH
Market value$31.03M
42.88%
Sole
1.01M
Shared
0.00
None
0.00
PRIME MEDICINE INC
DFNDShares1.79M
TypeSH
Market value$6.22M
8.59%
Sole
1.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INCDFND | COM | 1.27M | SH | $35.12M 48.53% | 1.27M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCDFND | COM NEW | 1.01M | SH | $31.03M 42.88% | 1.01M | 0.00 | 0.00 |
PRIME MEDICINE INCDFND | COM | 1.79M | SH | $6.22M 8.59% | 1.79M | 0.00 | 0.00 |